AUGMEDIX INC (AUGX)
US05105P1075 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.17M 34.53% | 30.93M 39.51% | 44.855M 45.02% | 54.162M 20.75% | 68.554M 26.57% | 63.24M -7.75% | |
| EBITDA YoY % growth | -16.86M -31.51% | -21.51M -27.58% | -17.681M 17.80% | -22.348M -26.40% | -17.986M 19.52% | -12.852M 28.54% | |
| EBIT YoY % growth | -17.55M -28.20% | -22.37M -27.46% | -18.779M 16.05% | -27.365M -45.72% | -22.918M 16.25% | 2.04M 108.90% | |
| Operating Margin | -79.16% | -72.32% | -41.87% | -50.52% | -33.43% | 3.23% | |
| EPS YoY % growth | N/A | N/A -5.15% | -0.45 31.78% | -0.54 -20.13% | -0.48 10.38% | -0.36 26.32% |
All data in USD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -39.40% | -0.12 -36.00% | -0.12 -2.00% | -0.10 25.46% | -0.09 37.81% | -0.07 41.67% |
| Revenue Q2Q % growth | 13.222M 12.37% | 17.639M 39.11% | 18.886M 40.20% | 20.3M 48.57% | 21.989M 66.31% | 24.674M 39.88% |
| EBITDA Q2Q % growth | -5.794M -60.49% | -5.131M -57.87% | -4.439M 25.56% | -3.679M 53.25% | -3.132M 45.94% | -2.809M 45.26% |
| EBIT Q2Q % growth | -6.796M -54.45% | -5.91M -35.94% | -5.58M 12.83% | -4.544M 47.92% | -3.774M 44.47% | -3.339M 43.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.13 -8.33% | -0.14 | 0.01 | 4.41% |
| Q1 2024 Q2Q % growth | -0.12 14.29% | -0.14 | 0.02 | 12.20% |
| Q4 2023 Q2Q % growth | -0.09 40.00% | -0.10 | 0.01 | 11.76% |
| Q3 2023 Q2Q % growth | -0.10 42.56% | -0.12 | 0.02 | 16.56% |
| Q2 2023 Q2Q % growth | -0.12 40.00% | -0.13 | 0.01 | 9.50% |
| Q1 2023 Q2Q % growth | -0.14 12.50% | -0.16 | 0.02 | 10.00% |
| Q4 2022 Q2Q % growth | -0.15 | -0.16 | 0.01 | 4.09% |
| Q3 2022 Q2Q % growth | 8.38% | -0.17 | % | |
| Q2 2022 Q2Q % growth | -0.20 -17.65% | -0.16 | -0.04 | -26.50% |
| Q1 2022 Q2Q % growth | -0.16 | -0.16 | 0.00 | -2.86% |
| Q4 2021 Q2Q % growth | -0.15 | -0.16 | 0.01 | 4.97% |
| Q3 2021 Q2Q % growth | -0.19 | -0.11 | -0.08 | -77.40% |
| Q2 2021 Q2Q % growth | -0.17 | -0.19 | 0.02 | 12.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 13.664M 26.75% | 13.909M | -245K | -1.76% |
| Q1 2024 Q2Q % growth | 13.471M 39.91% | 13.634M | -163K | -1.20% |
| Q4 2023 Q2Q % growth | 12.68M 44.91% | 12.715M | -35K | -0.28% |
| Q3 2023 Q2Q % growth | 11.767M 49.71% | 11.653M | 114K | 0.98% |
| Q2 2023 Q2Q % growth | 10.78M 47.07% | 10.579M | 201K | 1.90% |
| Q1 2023 Q2Q % growth | 9.628M 37.74% | 9.549M | 79K | 0.83% |
| Q4 2022 Q2Q % growth | 8.75M 32.98% | 8.684M | 66K | 0.76% |
| Q3 2022 Q2Q % growth | 7.86M 39.61% | 7.907M | -47K | -0.59% |
| Q2 2022 Q2Q % growth | 7.33M 41.78% | 7.481M | -151K | -2.02% |
| Q1 2022 Q2Q % growth | 6.99M 45.93% | 7.041M | -51K | -0.72% |
| Q4 2021 Q2Q % growth | 6.58M 44.93% | 6.525M | 55K | 0.84% |
| Q3 2021 Q2Q % growth | 5.63M 32.47% | 5.734M | -104K | -1.81% |
| Q2 2021 Q2Q % growth | 5.17M 38.61% | 5.282M | -112K | -2.12% |
| Q1 2021 Q2Q % growth | 4.79M 20.65% | % | ||
| Q4 2020 Q2Q % growth | 4.54M 14.65% | % | ||
| Q3 2020 Q2Q % growth | 4.25M 15.80% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 5.74% | 0% | 1.85% |
| Revenue | 0% | -4.06% | 0% | -2.64% |